Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle upon Tyne, England.
J Bone Joint Surg Am. 2013 Apr 17;95(8):702-9. doi: 10.2106/JBJS.L.00520.
Revision rates following unicondylar knee replacement vary among reporting institutions. Revision rates from institutions involved in the design of these implants and independent single-center series are comparable with those following total knee replacement, suggesting that higher operative volumes and surgical enthusiasm improve revision outcomes.
This registry-based cohort study involved the analysis of 23,400 medial cemented Oxford unicondylar knee replacements for the treatment of osteoarthritis. Total center and surgeon operative volumes were calculated over an eight-year time span since the inception of the registry (April 2003 to December 2010). The revision rate was calculated according to center volume and surgeon volume, each of which was grouped into five categories. The groups were compared with use of life tables, Kaplan-Meier plots, and Cox regression models that adjusted for variations in age, sex, and American Society of Anesthesiologists (ASA) grade among the groups.
A total of 919 surgeons and a total of 366 centers performed at least one replacement, with the majority performing a small number of procedures. The revision rate for the centers with the lowest volume (fifty or fewer procedures over the eight-year study period) was 1.62 (95% confidence interval [CI], 1.42 to 1.82) revisions per 100 component years; this was significantly higher than the rate for the centers with the highest volume (more than 400 procedures), which was 1.16 (95% CI, 0.97 to 1.36) revisions per 100 component years. The five-year implant survival rate of 92.3% (95% CI, 91.2% to 93.3%) for the lowest-volume centers was significantly lower than the rate of 94.1% (95% CI, 93.0% to 95.2%) for the highest-volume centers. Similarly, the revision rate for the surgeons with the lowest volume (twenty-five or fewer procedures), 2.16 (95% CI, 1.91 to 2.41) revisions per 100 component years, was significantly higher than that for the surgeons with the highest volume (more than 200 procedures), 0.80 (95% CI, 0.62 to 0.98) revisions per 100 component years. The five-year survival rate of 90.1% (95% CI, 88.8% to 91.3%) for the lowest-volume surgeons was also significantly lower than the rate of 96.0% (95% CI, 95.0% to 97.0%) for the highest-volume surgeons. When center and surgeon volume were considered simultaneously, the hazard of revision was greater for lower-volume surgeons at lower-volume centers compared with higher-volume surgeons at higher-volume centers (hazard ratio = 1.87 [95% CI, 1.58 to 2.22], p < 0.001).
High-volume centers and surgeons specializing in such procedures had superior results following unicondylar knee replacement compared with their low-volume counterparts. These results suggest that centers and surgeons should undertake a minimum of thirteen such procedures per year to achieve results comparable with the high-volume operators.
单髁膝关节置换术后的翻修率因报告机构而异。参与这些植入物设计的机构和独立的单中心系列的翻修率与全膝关节置换术的翻修率相当,这表明较高的手术量和手术积极性可以改善翻修结果。
本研究为基于注册的队列研究,共纳入了 23400 例接受骨水泥固定 Oxford 单髁膝关节置换术治疗骨关节炎的患者。在注册成立(2003 年 4 月至 2010 年 12 月)后的八年时间内,计算了中心和外科医生的总手术量。根据中心和外科医生的手术量计算翻修率,将每个手术量分为五组。使用寿命表、Kaplan-Meier 图和 Cox 回归模型对各组进行比较,该模型对各组之间的年龄、性别和美国麻醉师协会(ASA)分级的差异进行了调整。
共有 919 名外科医生和 366 家中心进行了至少一次置换手术,其中大多数外科医生进行的手术数量较少。在研究期间(八年)中,手术量最低(50 例以下)的中心的翻修率为每 100 个部件年 1.62 次(95%置信区间[CI],1.42 至 1.82),明显高于手术量最高(超过 400 例)的中心的翻修率 1.16 次(95%CI,0.97 至 1.36)。手术量最低的中心(5 年)的植入物存活率为 92.3%(95%CI,91.2%至 93.3%),明显低于手术量最高的中心(5 年)的 94.1%(95%CI,93.0%至 95.2%)。同样,手术量最低的外科医生(25 例以下)的翻修率为每 100 个部件年 2.16 次(95%CI,1.91 至 2.41),明显高于手术量最高的外科医生(200 例以上)的翻修率为 0.80 次(95%CI,0.62 至 0.98)。手术量最低的外科医生(5 年)的 90.1%(95%CI,88.8%至 91.3%)存活率也明显低于手术量最高的外科医生(5 年)的 96.0%(95%CI,95.0%至 97.0%)。当同时考虑中心和外科医生的手术量时,与高手术量中心的高手术量外科医生相比,低手术量中心的低手术量外科医生的翻修风险更高(风险比=1.87[95%CI,1.58 至 2.22],p<0.001)。
与低手术量的同行相比,高手术量的中心和专门从事此类手术的外科医生在单髁膝关节置换术后的结果更好。这些结果表明,中心和外科医生每年应至少进行 13 例此类手术,以获得与高手术量操作者相当的结果。